Abstract

Introduction/BackgroundWe investigated the relationship of programmed death-ligand 1(PD-L1) expression with clinicopathologic characteristics, to identify clinical significance of PD-1/PD-L1 immunotherapy in endometrial cancer.MethodologyTotal 232 patients with endometrial cancer were selected who...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call